Amendment: SEC Form SCHEDULE 13D/A filed by Performant Healthcare Inc.

Item 3 of Schedule 13D is amended and restated as follows: The information in Item 4 is incorporated herein by reference.

Item 4 of Schedule 13D is supplemented and superseded, as the case may be, as follows: On October 21, 2025 (the "Closing Date"), Continental Buyer, Inc., a Delaware corporation ("Parent"), completed the previously announced acquisition of Issuer, pursuant to the Agreement and Plan of Merger, dated as of July 31, 2025 (the "Merger Agreement"), by and among the Issuer, Parent and Project Prevail Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, on the Closing Date, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of Parent (the "Surviving Corporation"). At the effective time of the Merger (the "Effective Time"), each share of Common Stock issued and outstanding immediately prior to the Effective Time (other than any Common Stock held by (i) the Issuer as treasury stock or held directly by Parent or Merger Sub (or any direct or indirect wholly owned subsidiaries of the Issuer, Parent, or Merger Sub) or (ii) stockholders who have not voted in favor of, or consented in writing to, the adoption and approval of the Merger Agreement, and who are entitled to and have properly demanded appraisal of such Common Stock in accordance with Section 262 of the DGCL) was cancelled and converted into the right to receive an amount in cash, without interest, equal to $7.75. The description contained in this Item 4 of the Merger and the Merger Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement, which is described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on October 21, 2025 and is incorporated herein by reference.

Items 11 and 13 of each of the cover pages of this Schedule 13D are incorporated herein by reference.

Items 7 through 10 of each of the cover pages of this Schedule 13D are incorporated herein by reference.

Except as reported herein, there have been no transactions by the Reporting Persons in the class of securities reported on that were effected within the past 60 days.

The Reporting Persons do not beneficially own any shares of Common Stock.

As a result of the transaction described in Item 4, on October 21, 2025, each of the Reporting Persons ceased to be the beneficial owner of more than five percent (5%) of the outstanding securities of Issuer. The filing of this Amendment No. 7 represents the final amendment to the Schedule 13D and constitutes an exit filing for the Reporting Persons.

Item 6 of Schedule 13D is supplemented and superseded, as the case may be, as follows: The information in Item 4 is incorporated herein by reference.